Mela Sciences Announces 2013 Fourth Quarter And Year-End Financial Results
Published: Mar 18, 2014
MELA Sciences, Inc. (NASDAQ:MELA), (the “Company”), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in the diagnosis of melanoma, today announced financial results for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.